DuPont builds on previous commercialization of 1,3-propanediol (PDO) to develop markets for FDME

August 29, 2018 | Case Study

In January 2016, DuPont and Archer Daniels Midland (ADM) announced a breakthrough process for producing furan dicarboxylic methyl ester (FDME), a high-purity derivative of furandicarboxylic acid (FDCA), one of 12 plant-based building blocks identified by the U.S. Department of Energy that can be converted into high-value chemicals and materials. The platform is claimed to be more efficient and cost-competitive than traditional routes, making the molecule commercially viable. One of the first bio-based polymers under development is polytrimethylene furandicarboxylate (PTF), a near-drop-in to PET that can be used for similar downstream applications. After completing pilot-scale testing, DuPont and ADM opened a 60 tpa FDME demonstration facility in April 2018.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978